Stocks · Health care · Pharmaceutical Preparations

COLLEGIUM PHARMACEUTICAL, INC

COLL Clue Score59
United States Fiscal year ends December CIK 0001267565 Results filed 5 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Gino Santini
8 Jun 2026
Director
Exercised, kept
8,700
$16.49
$143.46K
John Gordon Freund
18 May 2026
Director
Sell
20
$34.05
$681.00
John Gordon Freund
15 May 2026
Director
Sold after exercise
4,127
$34.54
$142.55K
Nancy Lurker
13 May 2026
Director
Sell
4,500
$35.97
$161.86K
Garen G Bohlin
11 May 2026
Director
Sold after exercise
8,700
$37.18
$323.49K
David Dieter
18 Mar 2026
EVP & General Counsel
Sold on a plan
13,976
$34.92
$488.10K
David Dieter
9 Mar 2026
EVP & General Counsel
Sold on a plan
6,224
$36.65
$228.11K
Scott Dreyer
3 Mar 2026
EVP & Chief Commercial Officer
Sold on a plan
3,559
$40.99
$145.88K
Scott Dreyer
3 Mar 2026
EVP & Chief Commercial Officer
Sold on a plan
46,417
$40.36
$1.87M
Scott Dreyer
8 Dec 2025
EVP & Chief Commercial Officer
Sold after exercise
6,475
$48.66
$315.08K
Scott Dreyer
8 Dec 2025
EVP & Chief Commercial Officer
Sold after exercise
11,125
$47.89
$532.77K
Rita J. Balice-Gordon
5 Dec 2025
Director
Sell
3,650
$47.03
$171.67K
John A. Fallon
12 Nov 2025
Director
Sold after exercise
34,853
$47.21
$1.65M
Colleen Tupper
6 Nov 2025
EVP & Chief Financial Officer
Sold on a plan
4,858
$41.28
$200.52K
Colleen Tupper
6 Nov 2025
EVP & Chief Financial Officer
Sold on a plan
25,142
$40.38
$1.02M

What was left out

Form 4 filings counted 25
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 6
Sales straight out of an exercise 5
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 556,864
History held since 13 May 2015